{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:42:53Z","timestamp":1790091773166,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s15010-025-02722-6","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:32:00Z","timestamp":1767882720000},"page":"877-885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Linezolid versus clindamycin for toxin inhibition in severe skin and soft tissue infections: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"54","author":[{"given":"Ashton","family":"Stropes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Lautenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor D.","family":"Steuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2722_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.idc.2017.05.011","volume":"31","author":"S Bonne","year":"2017","unstructured":"Bonne S, Kadri SS. Evaluation and management of necrotizing soft tissue infections. Infect Dis Clin North Am. 2017;31:497\u2013511.","journal-title":"Infect Dis Clin North Am"},{"key":"2722_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1067\/j.cpsurg.2014.06.001","volume":"51","author":"TW Hakkarainen","year":"2014","unstructured":"Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51:344\u201362.","journal-title":"Curr Probl Surg"},{"key":"2722_CR3","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10-52.","journal-title":"Clin Infect Dis"},{"key":"2722_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13017-022-00406-2","volume":"17","author":"M Sartelli","year":"2022","unstructured":"Sartelli M, Coccolini F, Kluger Y, Agastra E, Abu-Zidan FM, Abbas AES, et al. WSES\/GAIS\/WSIS\/SIS-E\/AAST global clinical pathways for patients with skin and soft tissue infections. World J Emerg Surg. 2022;17:3.","journal-title":"World J Emerg Surg"},{"key":"2722_CR5","unstructured":"CDC. ABCs Bact Facts Interactive Data Dashboard [Internet]. Act. Bact. Core Surveill. ABCs. 2024 [cited 2025 Feb 25]. Available from: https:\/\/www.cdc.gov\/abcs\/bact-facts\/data-dashboard.html"},{"key":"2722_CR6","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","volume":"47","author":"EA Coyle","year":"2003","unstructured":"Coyle EA, Cha R, Rybak MJ. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin A release. Antimicrob Agents Chemother. 2003;47:1752\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"2722_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/ciac720","volume":"76","author":"N Cort\u00e9s-Penfield","year":"2023","unstructured":"Cort\u00e9s-Penfield N, Ryder JH. Should linezolid replace clindamycin as the adjunctive antimicrobial of choice in group A streptococcal necrotizing soft tissue infection and toxic shock syndrome? A focused debate. Clin Infect Dis Off Publ Infect Dis Soc Am. 2023;76:346\u201350.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2722_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5935\/0103-507X.20210025","volume":"33","author":"IT Peres","year":"2021","unstructured":"Peres IT, Hamacher S, Oliveira FLC, Bozza FA, Salluh JIF. Prediction of intensive care units length of stay: a concise review. Revista Brasileira de Terapia Intensiva. 2021;33:183\u20137.","journal-title":"Revista Brasileira de Terapia Intensiva"},{"key":"2722_CR9","doi-asserted-by":"crossref","unstructured":"Heil EL, Kaur H, Atalla A, Basappa S, Mathew M, Seung H, et al. Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open Forum Infect Dis [Internet]. 2023;10. Available from: https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2029594751&from=export","DOI":"10.1093\/ofid\/ofad588"},{"key":"2722_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad258","volume":"10","author":"J Dorazio","year":"2023","unstructured":"Dorazio J, Chiappelli AL, Shields RK, Tsai YV, Skinker P, Nabozny MJ, et al. Clindamycin plus vancomycin versus linezolid for treatment of necrotizing soft tissue infection. Open Forum Infect Dis. 2023;10:ofad258.","journal-title":"Open Forum Infect Dis"},{"key":"2722_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/sur.2021.329","volume":"23","author":"A Lehman","year":"2022","unstructured":"Lehman A, Santevecchi BA, Maguigan KL, Laconi N, Loftus TJ, Mohr AM, et al. Impact of empiric linezolid for necrotizing soft tissue infections on duration of methicillin-resistant Staphylococcus aureus-active therapy. Surg Infect. 2022;23:313\u20137.","journal-title":"Surg Infect"},{"issue":"24","key":"2722_CR12","first-page":"00507","volume":"S1473\u20133099","author":"A Babiker","year":"2024","unstructured":"Babiker A, Warner S, Li X, Chishti EA, Saad E, Swihart BJ, et al. Adjunctive linezolid versus clindamycin for toxin inhibition in \u03b2-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation. Lancet Infect Dis. 2024;S1473\u20133099(24):00507\u201313.","journal-title":"Lancet Infect Dis"},{"key":"2722_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1681\/ASN.20213210S1144a","volume":"32","author":"VV Suresh","year":"2021","unstructured":"Suresh VV, Mendoza Sanchez MA. Linezolid-associated interstitial nephritis: PO0307. J Am Soc Nephrol. 2021;32:144.","journal-title":"J Am Soc Nephrol"},{"key":"2722_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101367","volume":"11","author":"KM Clifford","year":"2022","unstructured":"Clifford KM, Selby AR, Reveles KR, Teng C, Hall RG, McCarrell J, et al. The risk and clinical implications of antibiotic-associated acute kidney injury: a review of the clinical data for agents with signals from the Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS) database. Antibiotics. 2022;11:1367.","journal-title":"Antibiotics"},{"key":"2722_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.12659\/AJCR.913779","volume":"20","author":"P Subedi","year":"2019","unstructured":"Subedi P, Chowdhury A, Tanovic K, Dumic I. Clindamycin: an unusual cause of acute kidney injury. Am J Case Rep. 2019;20:248\u201351.","journal-title":"Am J Case Rep"},{"key":"2722_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000354088","volume":"38","author":"H Xie","year":"2013","unstructured":"Xie H, Chen H, Hu Y, Xu S, He Q, Liu J, et al. Clindamycin-induced acute kidney injury: large biopsy case series. Am J Nephrol. 2013;38:179\u201383.","journal-title":"Am J Nephrol"},{"key":"2722_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2169\/internalmedicine.55.6084","volume":"55","author":"H Wan","year":"2016","unstructured":"Wan H, Hu Z, Wang J, Zhang S, Yang X, Peng T. Clindamycin-induced kidney diseases: a retrospective analysis of 50 patients. Intern Med. 2016;55:1433\u20137.","journal-title":"Intern Med"},{"key":"2722_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","volume":"68","author":"S Elyasi","year":"2012","unstructured":"Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012;68:1243\u201355.","journal-title":"Eur J Clin Pharmacol"},{"key":"2722_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/cpt.726","volume":"102","author":"EJ Filippone","year":"2017","unstructured":"Filippone EJ, Kraft WK, Farber JL. The nephrotoxicity of vancomycin. Clin Pharmacol Ther. 2017;102:459\u201369.","journal-title":"Clin Pharmacol Ther"},{"key":"2722_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad413","volume":"10","author":"AC Miller","year":"2023","unstructured":"Miller AC, Arakkal AT, Sewell DK, Segre AM, Tholany J, Polgreen PM. Comparison of different antibiotics and the risk for community-associated Clostridioides difficile infection: a case\u2013control study. Open Forum Infect Dis. 2023;10:ofad413.","journal-title":"Open Forum Infect Dis"},{"key":"2722_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/archinte.161.4.525","volume":"161","author":"E Mylonakis","year":"2001","unstructured":"Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile\u2013associated diarrhea: a review. Arch Intern Med. 2001;161:525\u201333.","journal-title":"Arch Intern Med"},{"key":"2722_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1514-2","volume":"16","author":"S Kundrapu","year":"2016","unstructured":"Kundrapu S, Sunkesula VCK, Jury LA, Cadnum JL, Nerandzic MM, Musuuza JS, et al. Do piperacillin\/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization? BMC Infect Dis. 2016;16:159.","journal-title":"BMC Infect Dis"},{"key":"2722_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ijantimicag.2012.01.005","volume":"39","author":"M Valerio","year":"2012","unstructured":"Valerio M, Pedromingo M, Mu\u00f1oz P, Alcal\u00e1 L, Marin M, Pel\u00e1ez T, et al. Potential protective role of linezolid against Clostridium difficile infection. Int J Antimicrob Agents. 2012;39:414\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"2722_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000001059","volume":"57","author":"MO Harhay","year":"2019","unstructured":"Harhay MO, Ratcliffe SJ, Small DS, Suttner LH, Crowther MJ, Halpern SD. Measuring and analyzing length of stay in critical care trials. Med Care. 2019;57:e53\u20139.","journal-title":"Med Care"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02722-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02722-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:54:34Z","timestamp":1774551274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02722-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02722-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}